dextromethorphan-quinidine for agitation in patients with alzheimer disease
Published 8 years ago • 2.5K plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
1:59
dextromethorphan-quinidine for agitation in patients with alzheimer disease
-
15:08
dextromethorphan pharmacology podcast
-
0:49
new alzheimer's drug shows clear reduction in cognitive degeneration
-
3:21
the memory network, psychosis network and the agitation network.
-
33:35
traffic and how to beat it - michael lederman
-
57:30
insights: an end for alzheimer’s disease
-
1:46
cdr-sb: improved sensitivity to treatment efficacy in future alzheimer's disease clinical trials
-
1:07
comt inhibitors for the treatment of parkinson’s
-
58:19
research connects i disease-modifying treatments and dementia
-
1:21
nicotinic receptor research
-
17:54
joe ecker: spatiotemporal dna methylome dynamics of the developing mouse fetus and beyond
-
38:17
cys-loop receptors part 7
-
1:24
sirtuins in kidney diseases: potential mechanism and therapeutic targets
-
1:24
research reveals potential role of calcineurin in protein aggregation related to parkinson's disease
-
1:37
citrus™ demo for cdisc
-
1:46
the vitamin d receptor on mouse immune cells participates in a sepsis-like condition
-
2:37
antibody helps detect protein implicated in alzheimer’s, other diseases
-
3:34
new alzheimer's drug shows promise in clinical trials
-
1:28
infective endocarditis in an iv drug abuser